Effect of intravenous levosimendan or milrinone on left atrial pressure in patients undergoing off-pump coronary artery bypass grafting-A prospective double-blind, randomized controlled trial

Conclusion: Levosimendan may be used as a primary inotrope in terms of better reduction in left atrial pressure during different stages of OPCAB, translating to a decrease in left ventricular end-diastolic pressure, therefore maintaining optimum coronary perfusion pressure, which is the primary goal of the surgery.PMID:37861575 | PMC:PMC10691577 | DOI:10.4103/aca.aca_51_23
Source: Annals of Cardiac Anaesthesia - Category: Anesthesiology Authors: Source Type: research